JPWO2020255906A1 - - Google Patents

Info

Publication number
JPWO2020255906A1
JPWO2020255906A1 JP2021528201A JP2021528201A JPWO2020255906A1 JP WO2020255906 A1 JPWO2020255906 A1 JP WO2020255906A1 JP 2021528201 A JP2021528201 A JP 2021528201A JP 2021528201 A JP2021528201 A JP 2021528201A JP WO2020255906 A1 JPWO2020255906 A1 JP WO2020255906A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021528201A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020255906A1 publication Critical patent/JPWO2020255906A1/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13Labelling of peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/16Aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate
    • C12N2310/3517Marker; Tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2021528201A 2019-06-20 2020-06-15 Pending JPWO2020255906A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019114690 2019-06-20
PCT/JP2020/023340 WO2020255906A1 (fr) 2019-06-20 2020-06-15 Corps lié pour agents de marquage fluorescents

Publications (1)

Publication Number Publication Date
JPWO2020255906A1 true JPWO2020255906A1 (fr) 2020-12-24

Family

ID=74040194

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021528201A Pending JPWO2020255906A1 (fr) 2019-06-20 2020-06-15

Country Status (4)

Country Link
US (1) US20220229047A1 (fr)
EP (1) EP3950701A4 (fr)
JP (1) JPWO2020255906A1 (fr)
WO (1) WO2020255906A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005075997A1 (fr) * 2004-02-03 2005-08-18 Asahi Kasei Kabushiki Kaisha Procede de detection d’analyte en utlisant un cordon magnetique
WO2015133523A1 (fr) * 2014-03-06 2015-09-11 コニカミノルタ株式会社 Agent de marquage de nanoparticules de phosphore intégrées, et procédé d'immunocoloration fluorescente l'utilisant
WO2015146896A1 (fr) * 2014-03-24 2015-10-01 コニカミノルタ株式会社 Procédé d'analyse quantitative de matériau biologique sur la base d'une immunocoloration à antigènes multiples

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012099364A2 (fr) * 2011-01-17 2012-07-26 Lg Electronics Inc. Kit d'amplification d'un signal détecté dans un capteur immunologique et procédé de détection d'un antigène cible utilisant celui-ci
JP5900489B2 (ja) 2011-03-25 2016-04-06 コニカミノルタ株式会社 免疫組織染色法、およびこれを用いた抗体医薬の有効性を判定する方法
US10323271B2 (en) * 2014-03-20 2019-06-18 Konica Minolta, Inc. Probe reagent and fish using probe reagent
US20180092993A1 (en) * 2016-09-01 2018-04-05 Life Technologies Corporation Compositions and methods for enhanced fluorescence

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005075997A1 (fr) * 2004-02-03 2005-08-18 Asahi Kasei Kabushiki Kaisha Procede de detection d’analyte en utlisant un cordon magnetique
WO2015133523A1 (fr) * 2014-03-06 2015-09-11 コニカミノルタ株式会社 Agent de marquage de nanoparticules de phosphore intégrées, et procédé d'immunocoloration fluorescente l'utilisant
WO2015146896A1 (fr) * 2014-03-24 2015-10-01 コニカミノルタ株式会社 Procédé d'analyse quantitative de matériau biologique sur la base d'une immunocoloration à antigènes multiples

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AAT BIOQUEST: "ReadiLink TM Protein Biotinylation Kit", カタログ, JPN6020030409, 2014, pages 1 - 2, XP055773677, ISSN: 0005104841 *
THERMO SCIENTIFIC: "Avidin-Biotin Technical Handbook", カタログ, JPN6020030410, 2009, pages 12 - 13, ISSN: 0005104842 *

Also Published As

Publication number Publication date
EP3950701A4 (fr) 2022-03-23
US20220229047A1 (en) 2022-07-21
WO2020255906A1 (fr) 2020-12-24
EP3950701A1 (fr) 2022-02-09

Similar Documents

Publication Publication Date Title
BR112021017339A2 (fr)
BR112019016141A2 (fr)
BR112021017939A2 (fr)
BR112021017738A2 (fr)
BR112021017892A2 (fr)
BR112021017782A2 (fr)
AU2020104490A5 (fr)
BR112021017637A2 (fr)
BR112019016142A2 (fr)
BR112019016138A2 (fr)
BR112021018168A2 (fr)
BR112021017728A2 (fr)
BR112021017234A2 (fr)
BR112021017355A2 (fr)
BR112021017703A2 (fr)
BR112021017173A2 (fr)
BR112021018102A2 (fr)
BR112021018584A2 (fr)
BR112021017083A2 (fr)
BR112021015080A2 (fr)
BR112021018093A2 (fr)
BR112021018084A2 (fr)
BR112021013944A2 (fr)
BR112021013128A2 (fr)
BR112021016821A2 (fr)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221223

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230711

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240109